Unknown

Dataset Information

0

Construction of asthma related competing endogenous RNA network revealed novel long non-coding RNAs and potential new drugs.


ABSTRACT: BACKGROUND:Asthma is a heterogeneous disease characterized by chronic airway inflammation. Long non-coding RNA can act as competing endogenous RNA to mRNA, and play significant role in many diseases. However, there is little known about the profiles of long non-coding RNA and the long non-coding RNA related competing endogenous RNA network in asthma. In current study, we aimed to explore the long non-coding RNA-microRNA-mRNA competing endogenous RNA network in asthma and their potential implications for therapy and prognosis. METHODS:Asthma-related gene expression profiles were downloaded from the Gene Expression Omnibus database, re-annotated with these genes and identified for asthma-associated differentially expressed mRNAs and long non-coding RNAs. The long non-coding RNA-miRNA interaction data and mRNA-miRNA interaction data were downloaded using the starBase database to construct a long non-coding RNA-miRNA-mRNA global competing endogenous RNA network and extract asthma-related differentially expressed competing endogenous RNA network. Finally, functional enrichment analysis and drug repositioning of asthma-associated differentially expressed competing endogenous RNA networks were performed to further identify key long non-coding RNAs and potential therapeutics associated with asthma. RESULTS:This study constructed an asthma-associated competing endogenous RNA network, determined 5 key long non-coding RNAs (MALAT1, MIR17HG, CASC2, MAGI2-AS3, DAPK1-IT1) and identified 8 potential new drugs (Tamoxifen, Ruxolitinib, Tretinoin, Quercetin, Dasatinib, Levocarnitine, Niflumic Acid, Glyburide). CONCLUSIONS:The results suggested that long non-coding RNA played an important role in asthma, and these novel long non-coding RNAs could be potential therapeutic target and prognostic biomarkers. At the same time, potential new drugs for asthma treatment have been discovered through drug repositioning techniques, providing a new direction for the treatment of asthma.

SUBMITTER: Liao Y 

PROVIDER: S-EPMC6954528 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Construction of asthma related competing endogenous RNA network revealed novel long non-coding RNAs and potential new drugs.

Liao Yifang Y   Li Ping P   Wang Yanxia Y   Chen Hong H   Ning Shangwei S   Su Dongju D  

Respiratory research 20200110 1


<h4>Background</h4>Asthma is a heterogeneous disease characterized by chronic airway inflammation. Long non-coding RNA can act as competing endogenous RNA to mRNA, and play significant role in many diseases. However, there is little known about the profiles of long non-coding RNA and the long non-coding RNA related competing endogenous RNA network in asthma. In current study, we aimed to explore the long non-coding RNA-microRNA-mRNA competing endogenous RNA network in asthma and their potential  ...[more]

Similar Datasets

| S-EPMC5805314 | biostudies-literature
| S-EPMC7229307 | biostudies-literature
| S-EPMC7453507 | biostudies-literature
| S-EPMC7039062 | biostudies-literature
| S-EPMC4748279 | biostudies-literature
| S-EPMC7945298 | biostudies-literature
| S-EPMC8606539 | biostudies-literature
| S-EPMC7580164 | biostudies-literature
| S-EPMC7407898 | biostudies-literature
| S-EPMC9130708 | biostudies-literature